Industrial - Pollution & Treatment Controls
Compare Stocks
2 / 10Stock Comparison
PCT vs ECVT
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
PCT vs ECVT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Industrial - Pollution & Treatment Controls | Chemicals - Specialty |
| Market Cap | $1.38B | $1.62B |
| Revenue (TTM) | $11M | $819M |
| Net Income (TTM) | $-225M | $-63M |
| Gross Margin | -10.4% | 22.6% |
| Operating Margin | -11.8% | 15.4% |
| Forward P/E | — | 24.0x |
| Total Debt | $776M | $431M |
| Cash & Equiv. | $157M | $197M |
PCT vs ECVT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 20 | May 26 | Return |
|---|---|---|---|
| PureCycle Technolog… (PCT) | 100 | 77.1 | -22.9% |
| Ecovyst Inc. (ECVT) | 100 | 119.6 | +19.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PCT vs ECVT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PCT is the clearest fit if your priority is growth exposure.
- Rev growth 5.9%, EPS growth 31.3%
- 5.9% revenue growth vs ECVT's 2.7%
- 0.8% yield; 1-year raise streak; the other pay no meaningful dividend
ECVT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 0.90
- 14.1% 10Y total return vs PCT's -25.3%
- Lower volatility, beta 0.90, Low D/E 71.4%, current ratio 2.64x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.9% revenue growth vs ECVT's 2.7% | |
| Quality / Margins | -7.7% margin vs PCT's -20.6% | |
| Stability / Safety | Beta 0.90 vs PCT's 2.45, lower leverage | |
| Dividends | 0.8% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +117.2% vs PCT's +16.2% | |
| Efficiency (ROA) | -4.2% ROA vs PCT's -23.4%, ROIC 4.2% vs -20.3% |
PCT vs ECVT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PCT vs ECVT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ECVT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ECVT is the larger business by revenue, generating $819M annually — 75.2x PCT's $11M. ECVT is the more profitable business, keeping -7.7% of every revenue dollar as net income compared to PCT's -20.6%. On growth, PCT holds the edge at +161.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $11M | $819M |
| EBITDAEarnings before interest/tax | -$105M | $136M |
| Net IncomeAfter-tax profit | -$225M | -$63M |
| Free Cash FlowCash after capex | -$176M | $84M |
| Gross MarginGross profit ÷ Revenue | -10.4% | +22.6% |
| Operating MarginEBIT ÷ Revenue | -11.8% | +15.4% |
| Net MarginNet income ÷ Revenue | -20.6% | -7.7% |
| FCF MarginFCF ÷ Revenue | -16.1% | +10.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +161.2% | +32.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -5.2% | +2.3% |
Valuation Metrics
ECVT leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.4B | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $2.0B | $1.9B |
| Trailing P/EPrice ÷ TTM EPS | -6.30x | -24.07x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 24.04x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 13.99x |
| Price / SalesMarket cap ÷ Revenue | 164.83x | 2.24x |
| Price / BookPrice ÷ Book value/share | 29.97x | 2.82x |
| Price / FCFMarket cap ÷ FCF | — | 23.23x |
Profitability & Efficiency
ECVT leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
ECVT delivers a -10.2% return on equity — every $100 of shareholder capital generates $-10 in annual profit, vs $-4 for PCT. ECVT carries lower financial leverage with a 0.71x debt-to-equity ratio, signaling a more conservative balance sheet compared to PCT's 16.91x. On the Piotroski fundamental quality scale (0–9), ECVT scores 6/9 vs PCT's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -4.1% | -10.2% |
| ROA (TTM)Return on assets | -23.4% | -4.2% |
| ROICReturn on invested capital | -20.3% | +4.2% |
| ROCEReturn on capital employed | -21.6% | +4.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 16.91x | 0.71x |
| Net DebtTotal debt minus cash | $619M | $234M |
| Cash & Equiv.Liquid assets | $157M | $197M |
| Total DebtShort + long-term debt | $776M | $431M |
| Interest CoverageEBIT ÷ Interest expense | -2.18x | 2.08x |
Total Returns (Dividends Reinvested)
ECVT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ECVT five years ago would be worth $12,247 today (with dividends reinvested), compared to $5,138 for PCT. Over the past 12 months, ECVT leads with a +117.2% total return vs PCT's +16.2%. The 3-year compound annual growth rate (CAGR) favors ECVT at 11.8% vs PCT's 0.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -14.9% | +48.1% |
| 1-Year ReturnPast 12 months | +16.2% | +117.2% |
| 3-Year ReturnCumulative with dividends | +2.7% | +39.7% |
| 5-Year ReturnCumulative with dividends | -48.6% | +22.5% |
| 10-Year ReturnCumulative with dividends | -25.3% | +14.1% |
| CAGR (3Y)Annualised 3-year return | +0.9% | +11.8% |
Risk & Volatility
ECVT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ECVT is the less volatile stock with a 0.90 beta — it tends to amplify market swings less than PCT's 2.45 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ECVT currently trades 98.3% from its 52-week high vs PCT's 43.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.45x | 0.90x |
| 52-Week HighHighest price in past year | $17.37 | $14.94 |
| 52-Week LowLowest price in past year | $4.93 | $6.54 |
| % of 52W HighCurrent price vs 52-week peak | +43.9% | +98.3% |
| RSI (14)Momentum oscillator 0–100 | 62.8 | 68.0 |
| Avg Volume (50D)Average daily shares traded | 4.6M | 2.2M |
Analyst Outlook
ECVT leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates PCT as "Buy" and ECVT as "Buy". Consensus price targets imply 18.1% upside for PCT (target: $9) vs -34.1% for ECVT (target: $10). PCT is the only dividend payer here at 0.82% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $9.00 | $9.67 |
| # AnalystsCovering analysts | 9 | 6 |
| Dividend YieldAnnual dividend ÷ price | +0.8% | — |
| Dividend StreakConsecutive years of raises | 1 | 2 |
| Dividend / ShareAnnual DPS | $0.06 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | +2.9% |
ECVT leads in 6 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics.
PCT vs ECVT: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is PCT or ECVT a better buy right now?
Analysts rate PureCycle Technologies, Inc.
(PCT) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — PCT or ECVT?
Over the past 5 years, Ecovyst Inc.
(ECVT) delivered a total return of +22. 5%, compared to -48. 6% for PureCycle Technologies, Inc. (PCT). Over 10 years, the gap is even starker: ECVT returned +14. 1% versus PCT's -25. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — PCT or ECVT?
By beta (market sensitivity over 5 years), Ecovyst Inc.
(ECVT) is the lower-risk stock at 0. 90β versus PureCycle Technologies, Inc. 's 2. 45β — meaning PCT is approximately 171% more volatile than ECVT relative to the S&P 500. On balance sheet safety, Ecovyst Inc. (ECVT) carries a lower debt/equity ratio of 71% versus 17% for PureCycle Technologies, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — PCT or ECVT?
On earnings-per-share growth, the picture is similar: PureCycle Technologies, Inc.
grew EPS 31. 3% year-over-year, compared to -916. 7% for Ecovyst Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — PCT or ECVT?
Ecovyst Inc.
(ECVT) is the more profitable company, earning -9. 8% net margin versus -21. 9% for PureCycle Technologies, Inc. — meaning it keeps -9. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ECVT leads at 9. 0% versus -1991. 2% for PCT. At the gross margin level — before operating expenses — ECVT leads at 21. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is PCT or ECVT more undervalued right now?
Analyst consensus price targets imply the most upside for PCT: 18.
1% to $9. 00.
07Which pays a better dividend — PCT or ECVT?
In this comparison, PCT (0.
8% yield) pays a dividend. ECVT does not pay a meaningful dividend and should not be held primarily for income.
08Is PCT or ECVT better for a retirement portfolio?
For long-horizon retirement investors, Ecovyst Inc.
(ECVT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 90)). PureCycle Technologies, Inc. (PCT) carries a higher beta of 2. 45 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ECVT: +14. 1%, PCT: -25. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between PCT and ECVT?
These companies operate in different sectors (PCT (Industrials) and ECVT (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
PCT pays a dividend while ECVT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.